NCT05704985 2025-05-29
Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors
DEKA Biosciences
Phase 1 Active not recruiting
DEKA Biosciences
Massachusetts General Hospital
Massachusetts General Hospital
H. Lee Moffitt Cancer Center and Research Institute
Massachusetts Eye and Ear Infirmary
Ascend Biopharmaceuticals Ltd